Prana Biosciences
Prana Biosciences develops antibody biologics to provide bio-better options to a wider patient population. It combines hybrid biotech and biomanufacturing, focusing on bio-better monoclonal antibodies using its own manufacturing platform and AI-supported enhancements in binding, function, and safety. Core technologies include antibody discovery and engineering, proprietary vectors and cell lines, and a contracted development and manufacturing organization model. The company targets biopharma partners and CDMO clients, aiming to scale production and broaden access to biologics.
Prana Biosciences
Prana Biosciences develops antibody biologics to provide bio-better options to a wider patient population. It combines hybrid biotech and biomanufacturing, focusing on bio-better monoclonal antibodies using its own manufacturing platform and AI-supported enhancements in binding, function, and safety. Core technologies include antibody discovery and engineering, proprietary vectors and cell lines, and a contracted development and manufacturing organization model. The company targets biopharma partners and CDMO clients, aiming to scale production and broaden access to biologics.